Femasys (FEMY) EBITDA Margin (2020 - 2025)
Femasys' (FEMY) quarterly EBITDA Margin came in at 941.09% in Q2 2025, up 108260.0% YoY from N/an in Q2 2024, and up 41.19% on a QoQ basis from 1600.11% in Q1 2025.
Femasys (FEMY) EBITDA Margin (2020 - 2025) Analysis & Trends
Femasys (FEMY) has 6 years of EBITDA Margin data on file, last reported at 941.09% in Q2 2025.
- Quarterly EBITDA Margin rose 108260.0% year-over-year to 941.09% in Q2 2025, while the trailing twelve-month figure through Jun 2025 was 1015.0% (up 71910.0% YoY) and the FY2025 annual result came in at 766.95%, up 32480.0% from the prior year.
- EBITDA Margin advanced to 941.09% in Q2 2025, from 1600.11% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 553.88% in Q1 2021 to a low of 2087.89% in Q4 2023.
- A 5-year average of 1117.75% and a median of 924.72% in 2024 frame the typical range for EBITDA Margin.
- The widest YoY moves for EBITDA Margin: up 127586 bps in 2024, down 110767 bps in 2024.
- Tracing FEMY's EBITDA Margin over 5 years: stood at 927.05% in 2021, then tumbled by 38 bps to 1280.87% in 2022, then plunged by 63 bps to 2087.89% in 2023, then surged by 61 bps to 812.03% in 2024, then decreased by 16 bps to 941.09% in 2025.
- The last three EBITDA Margin figures came in at 941.09% (Q2 2025), 1600.11% (Q1 2025), and 812.03% (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 33.60% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 13.31% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 0.39% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 30.66% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 5.14% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 20.53% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 8.19% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -2.87% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 7.33% |
| 10 | Femasys | 9.97 Mn | 8.53 Mn | 189,391.00 | -1,526.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -941.09% |
| Mar 31, 2025 | -1,600.11% |
| Dec 31, 2024 | -812.03% |
| Sep 30, 2024 | -922.39% |
| Jun 30, 2024 | -2,023.69% |
| Mar 31, 2024 | -1,277.07% |
| Dec 31, 2023 | -2,087.89% |
| Sep 30, 2023 | -1,670.18% |
| Jun 30, 2023 | -916.02% |
| Mar 31, 2023 | -1,034.64% |
| Dec 31, 2022 | -1,280.87% |
| Sep 30, 2022 | -879.88% |
| Jun 30, 2022 | -877.55% |
| Mar 31, 2022 | -896.92% |
| Dec 31, 2021 | -927.05% |
| Sep 30, 2021 | -835.16% |
| Jun 30, 2021 | -583.14% |
| Mar 31, 2021 | -553.88% |
| Dec 31, 2020 | -592.41% |
| Sep 30, 2020 | -499.63% |